Document Detail


Infant pertussis deaths and the management of cardiovascular compromise.
MedLine Citation:
PMID:  15009556     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Infants infected with Bordetella pertussis in the first few weeks of life are at risk of death from 'overwhelming cardiovascular compromise despite intensive care support'. The mechanisms of this severe disease are not completely understood. Three case histories, including that of one infant who survived, are presented. Two of the patients died despite intensive therapy with pressors and, in one child, milrinone. The third child survived following treatment with nitric oxide and sildenafil. Hence, sildenafil in combination with nitric oxide shows promise as a therapy for the haemodynamic consequences of pertussis toxaemia and this should prompt clinical trials for their efficacy for this condition.
Authors:
J A McEniery; R G Delbridge; D M Reith
Related Documents :
12107586 - Mri-based blood oxygen saturation measurements in infants and children with congenital ...
11371826 - Energy cost of walking in low lumbar myelomeningocele.
16856826 - Inhaled nitric oxide therapy might reduce the need for hyperventilation therapy in infa...
18198246 - The hypoxia challenge test does not accurately predict hypoxia in flight in ex-preterm ...
21034956 - Endoscopic management of a type iv syringocele causing massive perirenal urinoma in an ...
9401176 - Breastfeeding practices in indonesia.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of paediatrics and child health     Volume:  40     ISSN:  1034-4810     ISO Abbreviation:  J Paediatr Child Health     Publication Date:  2004 Apr 
Date Detail:
Created Date:  2004-03-10     Completed Date:  2004-09-10     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9005421     Medline TA:  J Paediatr Child Health     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  230-2     Citation Subset:  IM    
Affiliation:
Intensive Care, Royal Children's Hospital, Brisbane, Queensland, Australia. Julie_McEniery@health.qld.gov.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bordetella pertussis / isolation & purification
Cardiovascular Diseases / drug therapy*,  etiology*
Drug Therapy, Combination
Humans
Infant
Infant, Newborn
Male
Nitric Oxide / therapeutic use*
Piperazines / therapeutic use*
Purines
Sulfones
Vasodilator Agents / therapeutic use*
Whooping Cough / complications*,  microbiology,  mortality*
Chemical
Reg. No./Substance:
0/Piperazines; 0/Purines; 0/Sulfones; 0/Vasodilator Agents; 10102-43-9/Nitric Oxide; 139755-83-2/sildenafil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Growth hormone and insulin-like growth factor 1 levels and their relation to survival in children wi...
Next Document:  Genital abnormalities mimicking congenital adrenal hyperplasia in premature infants.